OR WAIT null SECS
August 01, 2014
New chemical entities with poor aqueous solubility require the use of technologies to enable sufficient oral bioavailability of these NCEs following administration.
Stephen Tindal from Catalent Pharma Solutions speaks with Pharmaceutical Technology Europe about advances in softgel technologies.
Softgels are now being recognised as one of the preferred dosage forms for the treatment of pain, eye conditions, cough and cold, as well as allergy.
Contract research, development, and manufacturing organizations invested in new facilities and technologies in 2014 for analytical testing, as well as small- and large-molecule drug development.
July 29, 2014
Study provides first substantive reference data on key quality attributes of empty capsules
July 11, 2014
Sun Pharma, Forest Pharmaceuticals and West-Ward Pharmaceuticals issue recalls over dissolution issues.
June 30, 2014
PolySciTech's new launch, SpinSwiper, has the potential to speed up microparticle production.
June 02, 2014
Industry experts share their perspectives on key advances in controlled-release drug delivery and future innovations in this arena.
May 30, 2014
FDA finalizes guidance on expedited programs for new drug approvals for treatment of serious and life-threatening conditions.
May 02, 2014
Industry experts discuss how extractables and leachables studies are designed using a risk-based approach.